| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |